fluconazole has been researched along with Pachymeningitis in 57 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amphotericin B used in combination with flucytosine has superior mycologic and clinical efficacy compared with fluconazole for the treatment of cryptococcal meningitis in patients with AIDS." | 9.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "The objective of this study is to describe the effectiveness of fluconazole among patients hospitalised for coccidioidomycosis despite recent outpatient fluconazole treatment." | 8.31 | Can fluconazole be used for inpatient re-treatment of coccidioidomycosis among patients with past fluconazole exposures? ( Gonzalez, O; Goodlet, KJ; Magdalany, AN; Nailor, MD, 2023) |
| "To assess the possible beneficial effects of combined therapy (fluconazole and flucytosine) in the treatment of cryptococcal meningitis in the immunocompromised host, we compared therapy with fluconazole and flucytosine, individually and combined, in the experimental murine model." | 7.68 | Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. ( Allendoerfer, R; Graybill, JR; Marquis, AJ; Rinaldi, MG, 1991) |
| "The detailed pharmacokinetics of fluconazole in serum and cerebrospinal fluid (CSF) were studied in a patient with acquired immunodeficiency syndrome and cryptococcal meningitis, after an intravenous dose of 400 mg." | 7.68 | Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis. ( Chin, T; Fong, IW; Vandenbroucke, A, 1990) |
| " After the patient failed to respond to both ketoconazole and amphotericin B, treatment with fluconazole brought about clinical resolution of meningitis and pulmonary disease and, in combination with repeated percutaneous aspiration, control of the arterial infection." | 7.68 | Infection of an arterial prosthesis as the presenting manifestation of disseminated coccidioidomycosis: control of disease with fluconazole. ( Fihn, SD; Miller, RA; Schwartz, DN, 1993) |
| " Cryptococcal meningitis is a common life-threatening infection in AIDS patients, usually treated with amphotericin B, often in combination with flucytosine." | 7.68 | Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. ( Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR, 1991) |
| "Experiments are described of the treatment of two patients with cryptococcal meningitis using antifungal drugs and amphotericin B." | 7.68 | Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B. ( Shindo, K, 1990) |
| " We compared fluconazole in murine cryptococcosis with ketoconazole and amphotericin B." | 7.67 | Treatment of cryptococcal meningitis in mice with fluconazole. ( Graybill, JR; Palou de Fernandez, E; Patino, MM; Tarbit, MH, 1986) |
| "The pharmacokinetics of fluconazole, a new oral azole, were evaluated in cerebrospinal fluid and sera of eight patients with coccidioidal meningitis." | 7.67 | Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. ( Arathoon, EG; Hanson, LH; Hartstein, AI; Levine, BE; Stevens, DA; Tucker, RM; Williams, PL, 1988) |
| "Twenty-two patients with AIDS and various forms of cryptococcosis were treated in an open-label study with 50 to 400 mg/day of fluconazole." | 7.67 | Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. ( Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ, 1988) |
| "Two patients with cryptococcal meningitis were treated with the investigational triazole drug fluconazole (UK-49,858)." | 7.67 | Treatment of two cases of cryptococcal meningitis with fluconazole. ( de Graeff-Meeder, ER; Kuis, W; Paul, LC; van 't Wout, JW; van Furth, R, 1988) |
| "In patients with the acquired immunodeficiency syndrome (AIDS), the rate of relapse after primary treatment for cryptococcal meningitis remains high." | 6.67 | A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J, 1991) |
| "Amphotericin B was more efficacious than fluconazole." | 5.27 | Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858). ( Ahrens, J; Graybill, JR; Sun, SH, 1986) |
| "Amphotericin B used in combination with flucytosine has superior mycologic and clinical efficacy compared with fluconazole for the treatment of cryptococcal meningitis in patients with AIDS." | 5.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "The objective of this study is to describe the effectiveness of fluconazole among patients hospitalised for coccidioidomycosis despite recent outpatient fluconazole treatment." | 4.31 | Can fluconazole be used for inpatient re-treatment of coccidioidomycosis among patients with past fluconazole exposures? ( Gonzalez, O; Goodlet, KJ; Magdalany, AN; Nailor, MD, 2023) |
| " The patient was initially treated with amphotericin B deoxycholate plus fluconazole for disseminated cryptococcosis, according to guideline recommendations." | 3.91 | Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report. ( Bay, MB; de Oliveira, AL; Freire, MG; Gomes, RMODS; Soares, RDA; Theodoro, RC; Vechi, HT, 2019) |
| " After the patient failed to respond to both ketoconazole and amphotericin B, treatment with fluconazole brought about clinical resolution of meningitis and pulmonary disease and, in combination with repeated percutaneous aspiration, control of the arterial infection." | 3.68 | Infection of an arterial prosthesis as the presenting manifestation of disseminated coccidioidomycosis: control of disease with fluconazole. ( Fihn, SD; Miller, RA; Schwartz, DN, 1993) |
| " Cryptococcal meningitis is a common life-threatening infection in AIDS patients, usually treated with amphotericin B, often in combination with flucytosine." | 3.68 | Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. ( Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR, 1991) |
| "The triazole SCH39304 was compared with itraconazole and fluconazole for treatment of murine coccidioidal meningitis." | 3.68 | Treatment of murine coccidioidal meningitis with SCH39304. ( Defaveri, J; Graybill, JR; Sun, SH, 1990) |
| "The triazole Bay R 3783 was compared with fluconazole, itraconazole, ketoconazole, and amphotericin B in rodent models of superficial and systemic candidiasis, meningocerebral cryptococcosis, and pulmonary aspergillosis." | 3.68 | Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. ( Hector, RF; Yee, E, 1990) |
| "The detailed pharmacokinetics of fluconazole in serum and cerebrospinal fluid (CSF) were studied in a patient with acquired immunodeficiency syndrome and cryptococcal meningitis, after an intravenous dose of 400 mg." | 3.68 | Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis. ( Chin, T; Fong, IW; Vandenbroucke, A, 1990) |
| "To assess the possible beneficial effects of combined therapy (fluconazole and flucytosine) in the treatment of cryptococcal meningitis in the immunocompromised host, we compared therapy with fluconazole and flucytosine, individually and combined, in the experimental murine model." | 3.68 | Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. ( Allendoerfer, R; Graybill, JR; Marquis, AJ; Rinaldi, MG, 1991) |
| "Experiments are described of the treatment of two patients with cryptococcal meningitis using antifungal drugs and amphotericin B." | 3.68 | Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B. ( Shindo, K, 1990) |
| "Clinical evaluation of fluconazole was performed on 12 cases of mycotic infections (7 cases of Candida esophagitis; one each case of cryptococcal meningitis with AIDS, Candida tropicalis fungemia and disseminated cryptococcosis in kidney transplant patient; 2 cases of Candida pneumonia)." | 3.67 | [Clinical evaluation of fluconazole]. ( Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M, 1989) |
| " In the treatment of experimental cryptococcal meningitis, SCH39304 was as effective as fluconazole in reducing yeast counts in the subarachnoid space." | 3.67 | Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. ( Durack, DT; Hobbs, MM; Perfect, JR; Wright, KA, 1989) |
| "The pharmacokinetics of fluconazole, a new oral azole, were evaluated in cerebrospinal fluid and sera of eight patients with coccidioidal meningitis." | 3.67 | Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. ( Arathoon, EG; Hanson, LH; Hartstein, AI; Levine, BE; Stevens, DA; Tucker, RM; Williams, PL, 1988) |
| "Two patients with cryptococcal meningitis were treated with the investigational triazole drug fluconazole (UK-49,858)." | 3.67 | Treatment of two cases of cryptococcal meningitis with fluconazole. ( de Graeff-Meeder, ER; Kuis, W; Paul, LC; van 't Wout, JW; van Furth, R, 1988) |
| "Twenty-two patients with AIDS and various forms of cryptococcosis were treated in an open-label study with 50 to 400 mg/day of fluconazole." | 3.67 | Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. ( Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ, 1988) |
| " We compared fluconazole in murine cryptococcosis with ketoconazole and amphotericin B." | 3.67 | Treatment of cryptococcal meningitis in mice with fluconazole. ( Graybill, JR; Palou de Fernandez, E; Patino, MM; Tarbit, MH, 1986) |
| "Fluconazole is a new antifungal agent from the class of triazoles for systemic treatment of fungal infections caused by Candida or Cryptococcus." | 2.67 | [Collection of cases in relation to clinical trials of fluconazole in Germany]. ( Krisch, H; Sarnow, E, 1990) |
| "In patients with the acquired immunodeficiency syndrome (AIDS), the rate of relapse after primary treatment for cryptococcal meningitis remains high." | 2.67 | A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J, 1991) |
| "We described here two Chinese AIDS patients with cryptococcal infections." | 2.61 | Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature. ( Cao, Q; Cooper, B; Gui, X; Sherer, R; Zhang, Y, 2019) |
| "Invasive fungal infections are major problems in immunocompromised patients and optimal therapeutical modalities are still far from optimal." | 2.38 | [Current progress in antifungal therapy: the value of fluconazole]. ( Meunier, F, 1990) |
| "Fluconazole is a recently approved agent for the treatment of certain fungal infections." | 2.38 | Fluconazole: a new triazole antifungal agent. ( Morrow, JD, 1991) |
| "I have tried to use the AIDS commentaries to keep up with these advances." | 2.38 | Azoles and AIDS. ( Larsen, RA, 1990) |
| "Fluconazole was continued orally later on." | 1.28 | [Isolated Candida albicans meningitis after treatment of B lymphoma]. ( Chevalier, MC; Damay, M; Gouraud, F; Jabado, N; Landman-Parker, J; Leverger, G; Varache, C, 1992) |
| "Treatment with amphotericin B, flucytosine and high doses of fluconazole was followed by clinical improvement, although CSF pleocytosis remained." | 1.28 | First report of chronic meningitis caused by Trichosporon beigelii. ( Boogaerts, M; Marcelis, L; Surmont, I; Verbist, L; Vergauwen, B; Verhoef, G, 1990) |
| "To assess the frequency of persistent Cryptococcus neoformans infection in patients with the acquired immunodeficiency syndrome (AIDS) after receiving apparently adequate treatment for meningitis." | 1.28 | Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group. ( Bozzette, S; Chiu, J; Larsen, RA; Leal, MA; McCutchan, JA; Richman, DD, 1989) |
| "Amphotericin B was more efficacious than fluconazole." | 1.27 | Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858). ( Ahrens, J; Graybill, JR; Sun, SH, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (29.82) | 18.7374 |
| 1990's | 30 (52.63) | 18.2507 |
| 2000's | 3 (5.26) | 29.6817 |
| 2010's | 6 (10.53) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Magdalany, AN | 1 |
| Nailor, MD | 1 |
| Gonzalez, O | 1 |
| Goodlet, KJ | 1 |
| Zhang, Y | 1 |
| Cooper, B | 1 |
| Gui, X | 1 |
| Sherer, R | 1 |
| Cao, Q | 1 |
| Damasceno-Escoura, AH | 1 |
| de Souza, ML | 1 |
| de Oliveira Nunes, F | 1 |
| Pardi, TC | 1 |
| Gazotto, FC | 1 |
| Florentino, DH | 1 |
| Mora, DJ | 1 |
| Silva-Vergara, ML | 1 |
| Vechi, HT | 1 |
| Theodoro, RC | 1 |
| de Oliveira, AL | 1 |
| Gomes, RMODS | 1 |
| Soares, RDA | 1 |
| Freire, MG | 1 |
| Bay, MB | 1 |
| Nelson, S | 1 |
| Vytopil, M | 1 |
| Mathisen, G | 1 |
| Shelub, A | 1 |
| Truong, J | 1 |
| Wigen, C | 1 |
| Vinh, DC | 1 |
| Stevens, DA | 2 |
| Kalavsky, E | 1 |
| Kisac, P | 1 |
| Huttova, M | 1 |
| Benca, J | 1 |
| Krcmery, V | 1 |
| Loschiavo, F | 1 |
| Ventura-Spagnolo, T | 1 |
| Sessa, E | 1 |
| Bramanti, P | 1 |
| Jiménez-Mejías, ME | 1 |
| Moreno-Maqueda, I | 1 |
| Regordan, C | 1 |
| Artola-Igarza, JL | 1 |
| Schwartz, DN | 1 |
| Fihn, SD | 1 |
| Miller, RA | 1 |
| Orni-Wasserlauf, R | 1 |
| Izkhakov, E | 1 |
| Siegman-Igra, Y | 1 |
| Bash, E | 1 |
| Polacheck, I | 1 |
| Giladi, M | 1 |
| Almoujahed, MO | 1 |
| Johnson, LB | 1 |
| Gehring, R | 1 |
| Khatib, R | 1 |
| Damay, M | 1 |
| Chevalier, MC | 1 |
| Gouraud, F | 1 |
| Jabado, N | 1 |
| Varache, C | 1 |
| Landman-Parker, J | 1 |
| Leverger, G | 1 |
| Bozzette, SA | 2 |
| Larsen, RA | 5 |
| Chiu, J | 3 |
| Leal, MA | 4 |
| Tilles, JG | 1 |
| Richman, DD | 2 |
| Leedom, JM | 1 |
| McCutchan, JA | 3 |
| Pottage, JC | 1 |
| Sha, BE | 1 |
| Coker, RJ | 2 |
| Harris, JR | 2 |
| Buxton, MJ | 1 |
| Dubois, DJ | 1 |
| Turner, RR | 1 |
| Sculpher, MJ | 1 |
| Robinson, PA | 1 |
| Searcy, C | 1 |
| Morrow, JD | 1 |
| Shindo, K | 1 |
| Jacobsen, J | 1 |
| Rothman, P | 1 |
| Robinson, P | 1 |
| Gilbert, G | 1 |
| Tilles, J | 1 |
| Good, CB | 1 |
| Leeper, HF | 1 |
| Poizot-Martin, I | 1 |
| Grob, JJ | 1 |
| Fournerie, JR | 1 |
| Dhiver, C | 1 |
| Andrac, L | 1 |
| Gastaut, JA | 1 |
| Bonerandi, JJ | 1 |
| Lindberg, J | 1 |
| Edebo, L | 1 |
| Allendoerfer, R | 1 |
| Marquis, AJ | 1 |
| Rinaldi, MG | 1 |
| Graybill, JR | 5 |
| Muñoz, J | 1 |
| Teira, R | 1 |
| Zubero, Z | 1 |
| Alvarez, M | 1 |
| Cisterna, R | 1 |
| Santamaría, JM | 1 |
| Krisch, H | 1 |
| Sarnow, E | 1 |
| Hector, RF | 1 |
| Yee, E | 1 |
| Defaveri, J | 1 |
| Sun, SH | 2 |
| Wright, KA | 2 |
| Perfect, JR | 3 |
| Ritter, W | 1 |
| Chan, LS | 1 |
| Meunier, F | 1 |
| Tomlinson, DR | 1 |
| Parkin, J | 1 |
| Pinching, AJ | 1 |
| Reents, SB | 1 |
| Powell, G | 1 |
| Surmont, I | 1 |
| Vergauwen, B | 1 |
| Marcelis, L | 1 |
| Verbist, L | 1 |
| Verhoef, G | 1 |
| Boogaerts, M | 1 |
| Taylor, GD | 1 |
| Boettger, DW | 1 |
| Miedzinski, LJ | 1 |
| Tyrrell, DL | 1 |
| Chin, T | 1 |
| Fong, IW | 1 |
| Vandenbroucke, A | 1 |
| Esposito, R | 1 |
| Foppa, CU | 1 |
| Antinori, S | 1 |
| Dietrich, D | 1 |
| Oka, S | 1 |
| Tokitsu, M | 1 |
| Mori, H | 1 |
| Nakata, H | 1 |
| Goto, M | 1 |
| Goto, H | 1 |
| Shimada, K | 1 |
| Bozzette, S | 1 |
| Hobbs, MM | 1 |
| Durack, DT | 2 |
| Levesque, H | 1 |
| Elie-Legrand, MC | 1 |
| Omnient, Y | 1 |
| Micaud, G | 1 |
| Lemeland, JF | 1 |
| Gancel, A | 1 |
| Courtois, H | 1 |
| Byrne, WR | 1 |
| Wajszczuk, CP | 1 |
| Tucker, RM | 1 |
| Williams, PL | 1 |
| Arathoon, EG | 1 |
| Levine, BE | 1 |
| Hartstein, AI | 1 |
| Hanson, LH | 1 |
| Foulds, G | 1 |
| Brennan, DR | 1 |
| Wajszczuk, C | 1 |
| Catanzaro, A | 1 |
| Garg, DC | 1 |
| Knopf, W | 1 |
| Rinaldi, M | 1 |
| Weidler, DJ | 1 |
| van 't Wout, JW | 1 |
| de Graeff-Meeder, ER | 1 |
| Paul, LC | 1 |
| Kuis, W | 1 |
| van Furth, R | 1 |
| Classen, DC | 1 |
| Burke, JP | 1 |
| Smith, CB | 1 |
| Stern, JJ | 1 |
| Hartman, BJ | 1 |
| Sharkey, P | 1 |
| Rowland, V | 1 |
| Squires, KE | 1 |
| Murray, HW | 1 |
| Dupont, B | 2 |
| Drouhet, E | 2 |
| Savani, DV | 1 |
| Ahrens, J | 1 |
| Palou de Fernandez, E | 1 |
| Patino, MM | 1 |
| Tarbit, MH | 1 |
5 reviews available for fluconazole and Pachymeningitis
| Article | Year |
|---|---|
Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Antifungal Agents; Antigen | 2019 |
Fluconazole: a new triazole antifungal agent.
Topics: Animals; Antifungal Agents; Candidiasis; Costs and Cost Analysis; Cryptococcosis; Fluconazole; Human | 1991 |
[Mollusca contagiosa-like cutaneous cryptococcosis in AIDS: a case].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Dermatomycoses; Diagnosis | 1991 |
Azoles and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ke | 1990 |
[Current progress in antifungal therapy: the value of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningit | 1990 |
4 trials available for fluconazole and Pachymeningitis
| Article | Year |
|---|---|
A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Cryptococcosis; Double-Blind Method; Drug Evaluatio | 1991 |
[Collection of cases in relation to clinical trials of fluconazole in Germany].
Topics: Adult; Candidiasis; Cryptococcosis; Female; Fluconazole; Humans; Male; Meningitis | 1990 |
Fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antifungal Agents; Candidiasis; Clinical Trials as Topi | 1990 |
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1990 |
48 other studies available for fluconazole and Pachymeningitis
| Article | Year |
|---|---|
Can fluconazole be used for inpatient re-treatment of coccidioidomycosis among patients with past fluconazole exposures?
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; Hospitalization; Humans; Inpatient | 2023 |
Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus gattii; DNA, Fu | 2019 |
Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
Topics: Acute Kidney Injury; Amphotericin B; Antifungal Agents; Bone Marrow; CD4-Positive T-Lymphocytes; Cer | 2019 |
Recurrence of coccidioidal meningitis after discontinuation of fluconazole.
Topics: Antifungal Agents; Brain; Coccidioidomycosis; Female; Fluconazole; Humans; Magnetic Resonance Imagin | 2013 |
Coccidioidal meningitis: clinical presentation and management in the fluconazole era.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin | 2010 |
Coccidioidal meningitis: disseminated disease in patients without HIV/AIDS.
Topics: Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Coccidioides; Coccidioidomyco | 2011 |
Coccidioidal meningitis.
Topics: Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Meningitis | 2006 |
Neuroinfections and antimicrobials: do we need new molecules or new strategies?
Topics: Anti-Infective Agents; Brain Diseases; Candidiasis; Cross Infection; Drug Resistance, Microbial; Flu | 2007 |
Acute meningitis from Cryptococcus neoformans (Filobasidiella neoformans) in a patient suffering from AIDS. Report of a clinical case with a favourable outcome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Cerebrospinal Fluid; Comorbidity; Cryptoco | 1993 |
[External cerebrospinal fluid diversion and Candida parapsilosis meningitis. Treatment with fluconazole].
Topics: Adult; Candidiasis; Cerebrospinal Fluid Shunts; Fluconazole; Humans; Male; Meningitis | 1993 |
Infection of an arterial prosthesis as the presenting manifestation of disseminated coccidioidomycosis: control of disease with fluconazole.
Topics: Aged; Blood Vessel Prosthesis; Coccidioidomycosis; Femoral Artery; Fluconazole; Humans; Lung Disease | 1993 |
Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, | 1999 |
Coccidioidal meningitis: incidental diagnosis 3 y after ventriculo-peritoneal shunt placement for hydrocephalus.
Topics: Antifungal Agents; Coccidioides; Fluconazole; Humans; Hydrocephalus; Male; Meningitis; Middle Aged; | 2002 |
[Isolated Candida albicans meningitis after treatment of B lymphoma].
Topics: Abdominal Neoplasms; Adolescent; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Can | 1992 |
Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Confidence Intervals; Cryptococcosis; Fluconazol | 1991 |
Development of histoplasmosis in a human immunodeficiency virus-infected patient receiving fluconazole.
Topics: Cryptococcosis; Fluconazole; Histoplasmosis; HIV Infections; Humans; Male; Meningitis; Middle Aged | 1991 |
Failure of fluconazole treatment in cryptococcal meningitis despite adequate CSF levels.
Topics: Adult; Cryptococcosis; Fluconazole; Humans; Male; Meningitis | 1991 |
Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Costs and Cost Analysis; C | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combinatio | 1990 |
Profound papilledema due to cryptococcal meningitis in acquired immunodeficiency syndrome: successful treatment with fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Fluconazole; Humans; Male | 1991 |
[Successful treatment of cryptococcal meningitis with fluconazole].
Topics: Aged; Cryptococcosis; Fluconazole; Humans; Male; Meningitis | 1991 |
Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis.
Topics: Amphotericin B; Animals; Chromatography, Gas; Cryptococcosis; Drug Therapy, Combination; Fluconazole | 1991 |
[Meningitis caused by Candida albicans in a patient with AIDS. Treatment with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Fluconazole; Humans; Male; Meningitis | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Crypto | 1990 |
Treatment of murine coccidioidal meningitis with SCH39304.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Evaluation, P | 1990 |
The pharmacokinetics of BAY R3783 and its efficacy in the treatment of experimental cryptococcal meningitis.
Topics: Animals; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Itraconazole; Ketoconazole; Meningiti | 1990 |
Interaction between fluconazole and rifampicin.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cryptococcosis; Drug Interactions; Fluconazole; Humans; M | 1990 |
Fluconazole success after amphotericin B and flucytosine failure in cryptococcal meningitis.
Topics: Adult; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans; Male; Meningitis | 1990 |
First report of chronic meningitis caused by Trichosporon beigelii.
Topics: Adolescent; Amphotericin B; Chronic Disease; Drug Therapy, Combination; Fluconazole; Flucytosine; Hu | 1990 |
Coccidioidal meningitis acquired during holidays in Arizona.
Topics: Administration, Oral; Aged; Alberta; Amphotericin B; Arizona; Coccidioides; Coccidioidomycosis; Fema | 1990 |
Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cryptococcus; Fluconazole; Half-Life; Humans; Injections, | 1990 |
Fluconazole for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Meningit | 1989 |
[AIDS: bad prognosis in candidiasis. Cryptococcosis in brain involvement is usually fatal--experiences with a new therapeutic drug].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningit | 1989 |
[Clinical evaluation of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Funga | 1989 |
Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus | 1989 |
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; | 1989 |
[Cryptococcus neoformans meningitis and cirrhosis. Value of fluconazole].
Topics: Aged; Aged, 80 and over; Cryptococcosis; Female; Fluconazole; Humans; Liver Cirrhosis; Meningitis | 1989 |
Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Flucon | 1988 |
Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis.
Topics: Adult; Aged; Antifungal Agents; Child; Coccidioidomycosis; Female; Fluconazole; Half-Life; Humans; M | 1988 |
Fluconazole penetration into cerebrospinal fluid in humans.
Topics: Fluconazole; Half-Life; Humans; Infusions, Intravenous; Meningitis; Triazoles | 1988 |
Treatment of two cases of cryptococcal meningitis with fluconazole.
Topics: Adolescent; Amphotericin B; Cryptococcosis; Cryptococcus; Female; Fluconazole; Humans; Male; Meningi | 1988 |
Treatment of coccidioidal meningitis with fluconazole.
Topics: Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Male; Meningitis; Middle Aged; Triazoles | 1988 |
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Antifungal Agents; Anti | 1988 |
Fluconazole for the treatment of fungal diseases in immunosuppressed patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; Flu | 1988 |
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immu | 1986 |
Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).
Topics: Amphotericin B; Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; Ketoconaz | 1986 |
Treatment of cryptococcal meningitis in mice with fluconazole.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Fluconazole; Ketoconazole; Kinetics; Men | 1986 |
Cryptococcal meningitis and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; M | 1987 |